JSE LIMITED - Acceptance of allocations of securities to directors, prescribed officers and the company secretary

Acceptance of allocations of securities to directors, prescribed officers and the company secretary

JSE LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2005/022939/06)
Share Code: JSE
ISIN: ZAE000079711
LEI: 213800MZ1VUQEBWRFO39
("JSE")

ACCEPTANCE OF ALLOCATIONS OF SECURITIES TO DIRECTORS, PRESCRIBED OFFICERS
AND THE COMPANY SECRETARY

The JSE LTIS 2018 Trust ("Trust") has acquired a total of 554 062 JSE
ordinary shares in the open market, with prior clearance, and on behalf of
participants in the JSE's Long-Term Incentive Scheme ("LTIS 2018"), as
previously disclosed. These JSE ordinary shares were acquired at a volume-
weighted average price ("VWAP") of R174.1761 per ordinary share.

Following the acquisition of the JSE ordinary shares by the Trust, the
executive directors, the prescribed officers and the Company Secretary have,
on 12 March 2026, accepted grants of restricted JSE ordinary shares, as
reflected below.

  Executive      Role            Total number    Total Rand value    Nature of
                                 of restricted   of restricted JSE   interest
                                 JSE ordinary    ordinary shares
                                 shares          awarded and
                                 awarded and     accepted
                                 accepted

  F Suliman      Group CFO &     64 064          11 158 418          Direct
                 Executive                                           beneficial
                 Director
  A Greenwood    Prescribed      48 846          8 507 806           Direct
                 Officer                                             beneficial

  V Lee          Prescribed      25 998          4 528 230           Direct
                 Officer                                             beneficial

  Q Mthembu      Prescribed      18 556          3 232 012           Direct
                 Officer                                             beneficial

  M Randall      Prescribed      41 106          7 159 683           Direct
                 Officer                                             beneficial

  T Tsoaeli      Prescribed      38 166          6 647 605           Direct
                 Officer                                             beneficial

  V Reddy        Prescribed      104 314         18 169 006          Direct
                 Officer                                             beneficial

  GA Brookes     Group Company   13 420          2 337 443           Direct
                 Secretary                                           beneficial



These ordinary shares are held by the LTIS 2018 participants on a direct
beneficial basis and are restricted until all vesting criteria (as defined)
are fulfilled.

The vesting of these restricted JSE ordinary shares is subject to –

(i)  the JSE achieving specified corporate performance targets over the
     measurement period; and
(ii) the LTIS 2018 participant remaining in the employ of the JSE for the
     vesting term (collectively "the vesting criteria").

To the extent that the vesting criteria are not fulfilled, the share awards
are forfeited.

The restricted shares will vest in two tranches, one-half on 1 March 2029
and the remaining half on 1 March 2030, subject to the vesting criteria
being met.

The individual allocations (grant and acceptance) were approved by the JSE's
Group Remuneration Committee.

Sandton
13 March 2026

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 13-03-2026 05:34:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.